Technical Analysis for AEMD - Aethlon Medical, Inc.
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Down | Down | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Calm After Storm | Range Contraction | 0.00% | |
Wide Bands | Range Expansion | 0.00% | |
Gapped Up | Strength | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
New 52 Week Closing Low | Bearish | 3.41% | |
New 52 Week Low | Weakness | 3.41% | |
Wide Bands | Range Expansion | 3.41% | |
Oversold Stochastic | Weakness | 3.41% | |
Calm After Storm | Range Contraction | -1.09% | |
Stochastic Reached Oversold | Weakness | -1.09% |
Alert | Time |
---|---|
60 Minute Opening Range Breakdown | about 14 hours ago |
60 Minute Opening Range Breakout | about 15 hours ago |
Rose Above Previous Day's High | about 15 hours ago |
1.5x Volume Pace | about 15 hours ago |
Up 5% | about 15 hours ago |
Get a Trading Assistant
- Earnings date: 02/12/2024
Aethlon Medical, Inc. Description
Aethlon Medical, Inc., a medical device company, focuses on creating devices for the treatment of cancer, infectious diseases, and other life-threatening conditions. It develops Aethlon Hemopurifier, a medical device that targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The company's Aethlon Hemopurifier addresses antiviral drug-resistance in hepatitis-C virus and human immunodeficiency virus infected individuals; serves as a countermeasure against viral pathogens not addressed by drug or vaccine therapies; and represents the therapeutic strategy to address cancer promoting exosomes. It is also developing exosome-based products to diagnose and monitor neurological disorders and cancer; and a therapeutic device to reduce the incidence of sepsis, a fatal bloodstream infection that often results in the death of combat-injured soldiers. The company was founded in 1991 and is based in San Diego, California.
Classification
Sector: Technology
Industry: Scientific & Technical Instruments
Keywords: Medicine Cancer Biology Infectious Diseases Treatment Of Cancer Coronavirus Neurological Disorders Hepatitis Viruses Immunodeficiency Urological Disorders Virus Antiviral Drug Exosome Sepsis Therapeutic Device Vesicles
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 5.0 |
52 Week Low | 1.3035 |
Average Volume | 8,643 |
200-Day Moving Average | 2.07 |
50-Day Moving Average | 1.62 |
20-Day Moving Average | 1.49 |
10-Day Moving Average | 1.43 |
Average True Range | 0.08 |
RSI (14) | 34.64 |
ADX | 29.14 |
+DI | 11.88 |
-DI | 33.57 |
Chandelier Exit (Long, 3 ATRs) | 1.54 |
Chandelier Exit (Short, 3 ATRs) | 1.53 |
Upper Bollinger Bands | 1.72 |
Lower Bollinger Band | 1.26 |
Percent B (%b) | 0.23 |
BandWidth | 30.91 |
MACD Line | -0.08 |
MACD Signal Line | -0.07 |
MACD Histogram | -0.0097 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.44 | ||||
Resistance 3 (R3) | 1.44 | 1.42 | 1.43 | ||
Resistance 2 (R2) | 1.42 | 1.40 | 1.42 | 1.43 | |
Resistance 1 (R1) | 1.39 | 1.39 | 1.38 | 1.39 | 1.42 |
Pivot Point | 1.37 | 1.37 | 1.36 | 1.37 | 1.37 |
Support 1 (S1) | 1.34 | 1.35 | 1.33 | 1.34 | 1.31 |
Support 2 (S2) | 1.31 | 1.33 | 1.31 | 1.30 | |
Support 3 (S3) | 1.29 | 1.31 | 1.30 | ||
Support 4 (S4) | 1.29 |